...peptides for cancer, autoimmunity, pain and inflammation. TargetsPP2A – Protein phosphatase 2A BC Staff Evotec SE Canaan Cedilla Therapeutics Inc. EdiGene Inc. Rappta Therapeutics LLC chs2020...

...to MEK inhibitors, the PP2A activator decreased tumor volume compared with vehicle. Next steps by Rappta Therapeutics LLC...
...cancer (CRPC). TARGET/MARKER/PATHWAY: Protein phosphatase 2 (PP2A; PPP2CA), KRAS (K-Ras) LICENSING STATUS: Patented; licensed to Rappta Therapeutics LLC...
...jukwes@utu.fi CONTACT: Goutham Narla, Case Western Reserve University, Cleveland, Ohio email: gnarla@med.umich.edu Sandi Wong Case Western Reserve University Rappta Therapeutics LLC University...